» Articles » PMID: 35869389

Implantable Vision-enhancing Devices and Postoperative Rehabilitation in Advanced Age-related Macular Degeneration

Overview
Journal Eye (Lond)
Specialty Ophthalmology
Date 2022 Jul 22
PMID 35869389
Authors
Affiliations
Soon will be listed here.
Abstract

Age-related macular degeneration (AMD) results in progressive vision loss that significantly impacts patients' quality of life and ability to perform routine daily activities. Although pharmaceutical treatments for AMD are available and in clinical development, patients with late-stage AMD are relatively underserved. Specialized rehabilitation programs and external low-vision aids are available to support visual performance for those with advanced AMD; but intraocular vision-improving devices, including implantable miniature telescope (IMT) and intraocular lens (IOL) implants, offer advantages regarding head motion, vestibular ocular reflex development, and depth perception. IMT and IOL technologies are rapidly evolving, and many patients who could benefit from them remain unidentified. This review of recent literature summarizes available information on implantable devices for improving vision in patients with advanced AMD. Furthermore, it discusses recent attempts of developing the quality of life tests including activities of daily life and objective assessments. This may offer the ophthalmologist but also the patient a better possibility to detect changes or improvements before and after surgery. It is evident that surgery with new implants/devices is no longer the challenge, but rather the more complex management of patients before and after surgery as well as the correct selection of cases.

Citing Articles

Anatomical and functional results of patients with late-stage age-related macular degeneration 6 months after smaller-incision new-generation implantable miniature telescope (SING IMT™) implantation.

Adamo G, Pellegrini M, Nasini F, Talli P, Sarti L, Perri P Eye (Lond). 2025; 39(3):544-547.

PMID: 39805963 PMC: 11794482. DOI: 10.1038/s41433-025-03598-4.


Exploring gellan gum-based hydrogels for regenerating human embryonic stem cells in age-related macular degeneration therapy: A literature review.

Moyo M, Adali T, Tulay P Regen Ther. 2024; 26:235-250.

PMID: 38966602 PMC: 11222715. DOI: 10.1016/j.reth.2024.05.018.


Optical-Quality Assessment of a Miniaturized Intraocular Telescope.

Nepita I, Raimondi R, Piazza S, Diaspro A, Vidal-Aroca F, Surdo S J Clin Med. 2023; 12(10).

PMID: 37240481 PMC: 10219409. DOI: 10.3390/jcm12103375.

References
1.
Borkenstein A, Borkenstein E . A case report detailing use of a new intraocular lens with advanced technology, designed specifically for patients with center-involving macular disorders. Medicine (Baltimore). 2019; 98(30):e16583. PMC: 6709155. DOI: 10.1097/MD.0000000000016583. View

2.
Pham R, Worrell B, Nguyen P, Narain K . Femtosecond laser-assisted cataract surgery and implantable miniature telescope. Am J Ophthalmol Case Rep. 2017; 7:40-49. PMC: 5722141. DOI: 10.1016/j.ajoc.2017.05.006. View

3.
Gheorghe A, Mahdi L, Musat O . AGE-RELATED MACULAR DEGENERATION. Rom J Ophthalmol. 2016; 59(2):74-7. PMC: 5712933. View

4.
Joondeph B . Anti-vascular endothelial growth factor injection technique for recurrent exudative macular degeneration in a telescope-implanted eye. Retin Cases Brief Rep. 2014; 8(4):342-4. DOI: 10.1097/ICB.0000000000000065. View

5.
Qureshi M, Robbie S, Hengerer F, Auffarth G, Conrad-Hengerer I, Artal P . Consecutive case series of 244 age-related macular degeneration patients undergoing implantation with an extended macular vision IOL. Eur J Ophthalmol. 2017; 28(2):198-203. DOI: 10.5301/ejo.5001052. View